Angiogenesis in human cancer: implications in cancer therapy

This publication has 66 references indexed in Scilit:

• Randomized Phase II Study of Temozolomide Given Every 8 Hours or Daily With Either Interferon Alfa-2b or Thalidomide in Metastatic Malignant Melanoma
  Journal of Clinical Oncology, 2003
• Phase II Trial of Thalidomide and Carmustine for Patients With Recurrent High-Grade Gliomas
  Journal of Clinical Oncology, 2003
• Bone Marrow Angiogenesis and Progression in Multiple Myeloma: Clinical Significance and Therapeutic Approach
  Leukemia & Lymphoma, 2003
• Clinical translation of angiogenesis inhibitors
  Nature Reviews Cancer, 2002
• Novel Antiangiogenic Effects of the Bisphosphonate Compound Zoledronic Acid
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis
  New England Journal of Medicine, 2000
• Therapy with thalidomide in refractory multiple myeloma patients — the revival of an old drug
  British Journal of Haematology, 2000
• What Is the Role of Thymidine Phosphorylase in Tumor Angiogenesis?
  JNCI: Journal of the National Cancer Institute, 1996
• Organ targeting In vivo using phage display peptide libraries
  Nature, 1996
• Approaches to studying cell adhesion molecules in angiogenesis
  Trends in Cell Biology, 1995